Susan Hasty, Publisher
Table of Contents . . . August 26th, 2002
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in AIDS Weekly | Other Publications
HIV/AIDS Pathogenesis - Humoral response may enhance viral infectivity
Pediatric HIV/AIDS - Protease inhibitor multitherapy has limited efficacy for infants
AIDS Therapy - Effectiveness of antiretroviral therapy demonstrated in Africa
AIDS Therapy - Long-term interruption of HIV treatment may be safe in certain patients
HIV/AIDS Dementia - High CSF viral loads presage neurological impairment
HIV/AIDS Vaccine - Antibody genes from patients induce broad antiviral activity
AIDS Conference - Drug resistance may prove more pervasive in African HIV
AIDS Therapy - Atazanavir improves cholesterol and triglyceride levels in HIV patients
AIDS Therapy - Tipranavir suppresses HIV/AIDS virus resistant to available protease inhibitors
Cholesterol - HIV patients switched to new protease inhibitor may have reductions in LDL, triglyceride levels
Drug Development - AnorMED selects new lead HIV drug candidate
HIV/AIDS Diagnosis - Novel immunoassay suitable for blood donor screening
Hepatitis B - Rights to low-dose oral interferon licensed in 40 African countries
Patient Education - Study offers new insights into overcoming disparities in health
Pediatrics - Antiretroviral therapy in HIV-infected children can stop neurological damage
Policy - Mandela to discuss making AIDS drugs available nationwide with current president
Therapy - Drugs can eradicate AIDS epidemic
Viral Replication - Achillion Pharmaceuticals launches phase II study of ACH-126,443
Virology - Extended- and immediate-release Zerit in combination with efavirenz show similar viral suppression
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.